Michael Carrier
@profmikecarrier
Professor at Rutgers Law School specializing in antitrust and IP law. @[email protected]
17-03-2013 20:53:51
5,9K Tweets
2,2K Followers
1,2K Following
Some say pharma patent thickets not concerning b/c high tech thickets even bigger. Relying on industry characteristics & empirical evidence on continuation patents, S. Sean Tu & I explain argument wrong and pharma thickets designed to be anticompetitive. papers.ssrn.com/sol3/papers.cf…